Analysts See 30% Growth Ahead for Boston Scientific
Analysts are projecting approximately 30% year-over-year growth for Boston Scientific (BSX) by 2026, driving bullish positioning on the stock. That growth rate, if realized, would significantly outperform the broader medical device peer group and support upward multiple expansion.